Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

BACKGROUND: Gefitinib is active in patients with pretreated non-small-cell lung cancer (NSCLC). We evaluated the activity and toxicity of gefitinib first-line treatment in advanced NSCLC followed by chemotherapy at disease progression. PATIENTS AND METHODS: In all, 63 patients with chemotherapy-naive stage IIIB/IV NSCLC received gefitinib 250 mg/day. At disease progression, gefitinib was replaced by cisplatin 80 mg/m(2) on day 1 and gemcitabine 1250 mg/m(2) on days 1, 8 for up to six 3-week cycles. Primary end point was the disease stabilization rate (DSR) after 12 weeks of gefitinib. RESULTS: After 12 weeks of gefitinib, the DSR was 24% and the response rate (RR) was 8%. Median time to progression (TtP) was 2.5 months and median overall survival (OS) 11.5 months. Never smokers (n = 9) had a DSR of 56% and a median OS of 20.2 months; patients with epidermal growth factor receptor (EGFR) mutation (n = 4) had a DSR of 75% and the median OS was not reached after the follow-up of 21.6 months. In all, 41 patients received chemotherapy with an overall RR of 34%, DSR of 71% and median TtP of 6.7 months. CONCLUSIONS: First-line gefitinib monotherapy led to a DSR of 24% at 12 weeks in an unselected patients population. Never smokers and patients with EGFR mutations tend to have a better outcome; hence, further trials in selected patients are warranted.

Na 50 Nachlass Arthur Schopenhauer - 'Schopenhauer-Archiv', 216 - Geburtstagswünsche zum 71. Geburtstag und Zusendung einer Übersetzung aus dem Sanskrit

veröffentlicht in: Schopenhauer, Arthur : Arthur Schopenhauers sämtliche Werke - München : Piper - Bd. 15 : Der Briefwechsel Arthur Schopenhauers ; 2 (1849 - 1860), Nr. 732

Partial pressure of carbon dioxide along the Transatlantic section from 7 November till 19 December 2000

Along a transatlantic section from 57°N to 60°S that was carried out from November 7 till December 19, 2000 on board R/V Horizont II concentrations of CO2 were measured in the near-water layer of the air and differences between partial pressures in water and air in various climatic zones were calculated. It was shown that variations of CO2 concentrations in the near-water layer of air and those of values of water-air partial pressure difference were from 324x10**-6 to 426x10**-6 and from 150x10**-6 to 100x10**-6 atm, respectively. Maximum value of CO2 partial pressure in air in the near-water layer (426x10**-6 atm) was noted at 45°-47°N; minimum of 324x10**-6 atm was found in Antarctica at 59°S. During measurenents maximum value of CO2 partial pressure difference in water and air (150 x10**-6) was observed at 45°-48°N; maximum flux in this case was directed from the atmosphere to water. Maximum value of CO2 partial pressure difference in water and air for flux directed from the ocean to air (100 x10**-6) was observed at 59°-60°S. Comparison of calculated values of partial pressure difference in water and air with previous data points to more intense exchange of CO2 between the ocean and atmosphere during the survey period was considered. According to values of CO2 partial pressure difference in air and water as compared to 1975, exchange intensity in the Northern Hemisphere (absorption from the atmosphere) increased. A well-pronounced latitudinal effect of distribution of CO2 partial pressure in air was observed. Along the route variations in CO2 concentrations in zones of water divergence and convergence were registered.